Newtown, PA—February 7, 2014—Connexion Healthcare announces the addition of Senior Vice President of the Oncology Center of Excellence. In this role, Mr Lunak will be responsible for the continued growth and developmentof the oncology business unit and will serve as a member of the management team.
Mr Lunak comes to Connexion Healthcare with more than 25 years of experience in healthcare communications and the pharmaceutical industry. Most recently, he founded and for 14 years served as Managing Partner of CREO Healthcare Communications,LLC & Oncology Associates, LLC, which provided innovative marketing solutions to support critical initiatives for leading pharmaceutical brands. Prior to that, at Bristol-Myers Squibb, he was Associate Director of Oncology Customer Marketing, Associate Director of Oncology Marketing, Senior Manager of Oncology Sales Analytics, and Territory Manager. As a marketing professional with Bristol-Myers Squibb for more than 10 years, he managed multiple high-volume brands and successfully established a new Customer Segment Marketing Department. This wide ranging expertise makes Mr Lunak a valuable asset to Connexion Healthcare.
Mr Lunak holds a Master’s degree in Business Administration from the University of Pittsburgh, Katz School of Business, in Pittsburgh, Pennsylvania. He earned a Bachelor of Science degree in chemical engineering with a minor in colloid, polymer and surfaces at Carnegie Mellon University, also in Pittsburgh, Pennsylvania.
Connexion Healthcare is comprised of 3 Centers of Excellence—Oncology, Rare Disease, and Neuroscience—and possesses core expertise in these therapeutic areas and the nuances involved in each therapeutic landscape. Within these Centers of Excellence, Connexion Healthcare conceives, develops, and executes scientific communications designed to elucidate the mechanisms, effects, and therapeutic roles of specific clinical entities through an orchestration of publications, presentations, and multimedia programming. Our esteemed medical directors and content development team, along with an accounts team rooted in science and best practices, are poised and ready to support brands in Phase II development through postlaunch.